Product image of Lindynette (Ethinylestradiol, Gestodene) supplied by GNH India

Lindynette

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Lindynette (Ethinylestradiol, Gestodene)

Ethinylestradiol / Gestodene, the active ingredient in Lindynette, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus, while also providing cycle control and reduced risk of unintended pregnancy when taken as directed.

GNH India supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lindynette, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual disorders.
  • Prevention of pregnancy: provides reliable contraception for women of childbearing potential.
  • Management of dysmenorrhea: reduces menstrual pain associated with ovulation.
  • Treatment of acne: improves hormonal acne in women by regulating androgen levels.

How It Works

  • Ethinylestradiol and gestodene act synergistically to suppress the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), thereby inhibiting ovulation. The estrogen component stabilises the endometrial lining, while the progestogen thickens cervical mucus and induces endometrial changes that prevent implantation. Together they maintain consistent hormone levels that mimic the natural menstrual cycle, providing effective contraception.

Side Effects

Like all hormonal contraceptives, Lindynette may be associated with a range of adverse reactions.

Common Side Effects

  • Nausea or mild gastrointestinal discomfort.
  • Breast tenderness or enlargement.
  • Headache or migraine onset.
  • Spotting or breakthrough bleeding between periods.
  • Weight fluctuation or fluid retention.
  • Mood changes or mild depression.

Serious or Rare Side Effects

  • Venous thromboembolism, including deep‑vein thrombosis or pulmonary embolism.
  • Arterial thrombosis such as stroke or myocardial infarction.
  • Severe hypertension or hypertensive crisis.
  • Liver dysfunction, including cholestatic jaundice.
  • Anaphylactic or severe allergic reactions.

Precautions & Warnings

  • Before prescribing Lindynette, clinicians should evaluate individual risk factors and ensure appropriate patient counseling.
  • Assess cardiovascular risk: evaluate history of thromboembolic events before prescribing.
  • Screen for liver disease: avoid use in active hepatic dysfunction.
  • Consider smoking status: contraindicated in women over 35 who smoke.
  • Review medication history: identify potential drug interactions that may reduce efficacy.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Lindynette can interact with several medicines that affect hormone metabolism or efficacy.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) may markedly reduce contraceptive effectiveness.
  • Rifampicin or other strong CYP3A4 inducers can lead to breakthrough bleeding.
  • St. John's wort may decrease plasma hormone levels, compromising contraception.

Moderate Interactions (Monitor Closely)

  • Antibiotics such as tetracycline or metronidazole may slightly lower efficacy; advise backup contraception.
  • Antifungal agents (e.g., ketoconazole, itraconazole) can increase hormone concentrations, raising risk of side effects.
  • Diuretics may affect fluid balance and blood pressure; monitor patient response.

Frequently Asked Questions

Lindynette is a combined oral contraceptive containing ethinylestradiol and gestodene. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus, and it can also help regulate menstrual cycles and improve hormonal acne when indicated.

The estrogen component, ethinylestradiol, stabilises the endometrial lining, while the progestogen gestodene suppresses the mid‑cycle surge of luteinising hormone and follicle‑stimulating hormone. This dual action blocks ovulation, thickens cervical mucus, and creates an endometrial environment that is unsuitable for implantation.

The dosing regimen for Lindynette is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription label, but the exact regimen should always be confirmed with the prescriber.

Lindynette is intended for use only when pregnancy is not desired; it should be discontinued if pregnancy occurs. Its safety during pregnancy has not been established, and it is generally not recommended for breastfeeding women without medical advice, as hormone levels may affect milk production.

To request Lindynette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lindynette combines ethinylestradiol with gestodene, a third‑generation progestogen that is associated with a lower androgenic profile compared with older progestins. This may result in fewer androgen‑related side effects such as acne, while providing contraceptive efficacy comparable to other combined oral contraceptives.

Lindynette tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Lindynette is taken orally, usually once daily at the same time each day. The tablets are swallowed whole with water, and the typical cycle includes 21 active tablets followed by a hormone‑free interval, unless a different regimen is prescribed by the healthcare provider.

Serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial thrombosis (stroke or myocardial infarction), severe hypertension, and liver disorders. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid using Lindynette.

Lindynette is contraindicated in women with a known hypersensitivity to ethinylestradiol or gestodene, active or past thromboembolic disease, uncontrolled hypertension, severe liver disease, or in smokers over 35 years of age. It should also be avoided during pregnancy and in individuals with certain hormone‑dependent cancers.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT